Voyager Therapeutics, Inc. (VYGR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 02:13PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 461.21M |
| Enterprise Value | 250.63M |
| Trailing P/E | 2.86 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.51 |
| Price/Book (mrq) | 1.95 |
| Enterprise Value/Revenue | 1.00 |
| Enterprise Value/EBITDA | 1.98 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.98 |
| 52-Week Change 3 | -29.45% |
| S&P500 52-Week Change 3 | 26.16% |
| 52 Week High 3 | 14.34 |
| 52 Week Low 3 | 6.06 |
| 50-Day Moving Average 3 | 8.79 |
| 200-Day Moving Average 3 | 8.17 |
Share Statistics
| Avg Vol (3 month) 3 | 677.15k |
| Avg Vol (10 day) 3 | 472.63k |
| Shares Outstanding 5 | 54.39M |
| Implied Shares Outstanding 6 | 54.39M |
| Float 8 | 37.2M |
| % Held by Insiders 1 | 16.91% |
| % Held by Institutions 1 | 57.21% |
| Shares Short (Apr 30, 2024) 4 | 4.21M |
| Short Ratio (Apr 30, 2024) 4 | 7.48 |
| Short % of Float (Apr 30, 2024) 4 | 9.24% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 7.74% |
| Shares Short (prior month Mar 28, 2024) 4 | 3.33M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | -2.56% |
| Operating Margin (ttm) | -82.92% |
Management Effectiveness
| Return on Assets (ttm) | -2.65% |
| Return on Equity (ttm) | -1.09% |
Income Statement
| Revenue (ttm) | 119.04M |
| Revenue Per Share (ttm) | 2.53 |
| Quarterly Revenue Growth (yoy) | -87.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -12.49M |
| Net Income Avi to Common (ttm) | -3.04M |
| Diluted EPS (ttm) | 2.97 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 399.57M |
| Total Cash Per Share (mrq) | 7.35 |
| Total Debt (mrq) | 47.94M |
| Total Debt/Equity (mrq) | 14.06% |
| Current Ratio (mrq) | 5.64 |
| Book Value Per Share (mrq) | 6.28 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 13.12M |
| Levered Free Cash Flow (ttm) | 70.52M |
© 2024 Yahoo. All rights reserved.